AOD-9604 — 5 mg

£24.99

  • ≥99% Purity (HPLC)
  • Batch-tested & CoA available
  • For research use only

 

AOD-9604 is a research peptide derived from the C-terminal region of human growth hormone, used in controlled in-vitro studies of growth-factor–adjacent signalling, peptide pharmacology, and assay development under non-clinical conditions.

This hGH-fragment analogue is selected in model systems to explore structure–activity relationships and receptor-adjacent pathway readouts. All work is conducted in laboratory settings only.
For laboratory research only. Not for human use.

FOR LABORATORY RESEARCH USE ONLY

This product is supplied exclusively for scientific laboratory research. It is not intended for human or veterinary use or administration, therapeutic use, diagnostic use or clinical application.

Avanti Peptides does not provide advice regarding human administration, dosage, injection, reconstitution for administration, treatment protocols or therapeutic use.

Regulatory status

This product is sold as a laboratory research material and is not offered or promoted as a medicinal product. No therapeutic or medical claims are made for this product.

SKU: AOD-9604-5MG Category: Tags: , ,

Description

≥99% Purity (HPLC)
Batch-tested & CoA available
Lyophilised — stable at room temp
For research use only

Product overview

AOD-9604 is a modified analogue of the lipolytic C-terminal domain of human growth hormone (hGH), corresponding to residues 177–191 of hGH with an additional Tyr at the N-terminus. Its sequence is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with a disulfide bond between Cys¹⁶²–Cys¹⁸⁹. AOD-9604 has been studied in vitro for its interactions with lipolytic signalling pathways and hGH receptor binding, specifically within the context of adipocyte biology and lipid metabolism research. Avanti Peptides supplies AOD-9604 as a lyophilised solid for stable, reproducible research.

Why researchers choose Avanti AOD-9604: hGH lipolytic domain analogue for SAR and lipid-pathway studies — manufactured via validated SPPS and released only after identity, purity (≥99% HPLC), and appearance QC.

Key features

  • hGH C-terminal lipolytic domain analogue for adipocyte and SAR investigations
  • Contains disulfide bond — verify under non-reducing conditions
  • Lyophilised solid — stable, easy to store, and straightforward to reconstitute
  • Unit size: 5 mg per vial
  • Every batch released only after stringent identity, purity, and appearance QC
  • Certificate of Analysis (CoA) and batch documentation available on request

Technical specifications

Product name AOD-9604
Synonyms Anti-Obesity Drug 9604; hGH fragment 177–191 (Tyr-modified)
Class hGH C-terminal fragment analogue (lipolytic, research use)
CAS number 221231-10-3
Molecular weight ~1817.1 g/mol
Purity ≥99% (HPLC)
Physical form Lyophilised powder
Appearance White to off-white solid
Unit size 5 mg / vial
Note Contains disulfide bond (Cys¹⁶²–Cys¹⁸⁹); handle under non-reducing conditions

Reconstitution & storage

  1. Before reconstitution: Store lyophilised vials at 2–8 °C, protected from light and moisture.
  2. Equilibrate: Allow vial and diluent to reach room temperature before opening.
  3. Reconstitute: Add Bacteriostatic Water (10 ml recommended). Swirl gently — do not vortex.
  4. After reconstitution: Store at 2–8 °C. Prepare aliquots to minimise freeze–thaw cycles.
  5. Compatibility: Use only within protocols that comply with your institution’s SOPs and local regulations.

Looking for complementary materials? See Bacteriostatic Water 10 ml and related hGH-domain research companions such as HGH-Frag 176–191.

About AOD-9604 in research

Researchers use AOD-9604 to study the lipolytic signalling activity of the hGH C-terminal domain in adipocyte and lipid-metabolism cell models. The Tyr substitution at position 177 distinguishes it from the canonical HGH-Frag 176–191 and enables comparative SAR studies of the lipolytic domain’s receptor-interaction profile.

Synthesis & quality assurance

Avanti Peptides manufactures AOD-9604 via controlled, validated solid-phase peptide synthesis (SPPS) with appropriate oxidative folding to form the disulfide bond, delivering high purity and lot-to-lot consistency. Each batch undergoes identity verification, HPLC purity analysis (≥99%), and appearance inspection before release.

FAQs

What is AOD-9604?
AOD-9604 is a synthetic analogue of the hGH C-terminal lipolytic domain (residues 177–191, Tyr-modified), used exclusively for in-vitro laboratory research into adipocyte biology, lipid-metabolism signalling, and hGH receptor SAR studies.
How should I store the peptide?
Store lyophilised vials at 2–8 °C, away from light and moisture. After reconstitution, keep at 2–8 °C and use aliquots to minimise freeze–thaw cycles.
What diluent should I use for reconstitution?
Most laboratories use Bacteriostatic Water (10 ml). Always follow your lab’s standard operating procedures (SOPs) for the specific assay.
Do you provide batch documentation / Certificate of Analysis?
Yes. Batch documentation including test results (CoA) is available on request. If it is not attached to your order confirmation, contact our support team and we will add it immediately.
Is this product intended for human use?
No. This material is strictly for laboratory research only and is not intended for human consumption, clinical application, or veterinary use.

Legal & safety notice

For research use only. Avanti Peptides supplies this material strictly for laboratory research. This product is not a medication, food supplement, or cosmetic and is not intended for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will handle the material in accordance with your institution’s policies and all applicable laws and regulations.

External resources for researchers

Related products